Compare Immunovant Inc. Common Stock (IMVT) vs SK Hynix (SKHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs SK Hynix — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while SK Hynix trades at $169.7 (market cap $891.31B). The key difference: SK Hynix is far larger — about 142.6× Immunovant Inc. Common Stock's market cap, and SK Hynix pays a 0.06% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and SK Hynix for 10 Days on average.
| IMVT | SKHY | |
|---|---|---|
Market Cap | $6.25B | $891.31B |
Volume | 1,755,411 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $44.96 | $198.63 |
52-Week Low | $17.03 | $126.79 |
Typical Hold Time | 1 Days | 10 Days |
Enterprise Value | $5.35B | $841.45B |
Dividend Yield | — | 0.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About SK Hynix
SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →
